Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Unraveling the mystery of prognostic and predictive factors in epidermal growth factor receptor therapy.

× No keyword cloud information.

31 in total

1. Targeted therapies: optimal first-line therapy for NSCLC with EGFR mutations.

Authors: Joel W Neal; Lecia V Sequist
Journal: Nat Rev Clin Oncol Date: 2010-02 Impact factor: 66.675

Review 2. Recent progress and clinical importance on pharmacogenetics in cancer therapy.

Authors: Thomas I Peng Soh; Wei Peng Yong; Federico Innocenti
Journal: Clin Chem Lab Med Date: 2011-09-28 Impact factor: 3.694

3. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates.

Authors: Mei Tian; Kazuma Ogawa; Richard Wendt; Uday Mukhopadhyay; Julius Balatoni; Nobuyoshi Fukumitsu; Rajesh Uthamanthil; Agatha Borne; David Brammer; James Jackson; Osama Mawlawi; Bijun Yang; Mian M Alauddin; Juri G Gelovani
Journal: J Nucl Med Date: 2011-05-13 Impact factor: 10.057

4. Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index.

Authors: Mu-Tai Liu; Wen-Tao Huang; Ai-Yih Wang; Chia-Chun Huang; Chao-Yuan Huang; Tung-Hao Chang; Chu-Pin Pi; Hao-Han Yang
Journal: Support Care Cancer Date: 2009-11-11 Impact factor: 3.603

5. Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma.

Authors: Young Joo Lee; In Kyu Park; Moo-Suk Park; Hye Jin Choi; Byoung Chul Cho; Kyung Young Chung; Se Kyu Kim; Joon Chang; Jin Wook Moon; Hoguen Kim; Sung Ho Choi; Joo-Hang Kim
Journal: J Cancer Res Clin Oncol Date: 2009-06-11 Impact factor: 4.553

6. Reduced Erlotinib sensitivity of epidermal growth factor receptor-mutant non-small cell lung cancer following cisplatin exposure: a cell culture model of second-line erlotinib treatment.

Authors: Tan Min Chin; Margaret P Quinlan; Anurag Singh; Lecia V Sequist; Thomas J Lynch; Daniel A Haber; Sreenath V Sharma; Jeffrey Settleman
Journal: Clin Cancer Res Date: 2008-11-01 Impact factor: 12.531

7. EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma.

Authors: Maria I Toki; Daniel E Carvajal-Hausdorf; Mehmet Altan; Joseph McLaughlin; Brian Henick; Kurt A Schalper; Konstantinos N Syrigos; David L Rimm
Journal: J Thorac Oncol Date: 2016-07-20 Impact factor: 15.609

Unraveling the mystery of prognostic and predictive factors in epidermal growth factor receptor therapy.